{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260608285348/en/Spruce-Biosciences-Announces-Long-Term-Tralesinidase-Alfa-Enzyme-Replacement-Therapy-Data-in-Sanfilippo-Syndrome-Type-B-MPS-IIIB-Presented-at-the-18th-International-MPS-Symposium", "message": "News view counter 786945 successfully enlarged"}